SCHEMBL8550970

SCHEMBL8550970

N=c1c2ccccc2c(=N)c2ccc1c1[nH]c3c(c21)CC=CC=C3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20146143 0.71 KIF11 (0.43)
SCHEMBL7079413 0.69 MEN1 (0.41)
SCHEMBL28983414 0.63 ALOX15 (0.52)
SCHEMBL8550975 0.62 POLB (0.43)
SCHEMBL24726998 0.62 HTR7 (0.39)
SCHEMBL20725511 0.61 GABRP (0.43)
SCHEMBL16311858 0.60 MEN1 (0.36)
SCHEMBL20083348 0.59 KDM4E (0.30)
SCHEMBL24633146 0.59 GPR3 (0.33)
SCHEMBL23863477 0.59 MAPT (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed